Lymphoproliferative syndrome in an infant after stem cell transplantation: successful therapy with T-lymphocytes and anti-CD20 monoclonal antibodies.
Stachel
D K
DK
Department of Hematology-Oncology, Children's Hospital of the University of Munich, Dr. von Haunersches Kinderspital, University of Munich, Munich, Germany. Daniel.Stachel@kk-i.med.uni-muenchen.de
Schmid
I
I
Schuster
F
F
Stehr
M
M
Baumeister
F A
FA
Müller-Höcker
J
J
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D020031:Epstein-Barr Virus Infections / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D007223:Infant; D008232:Lymphoproliferative Disorders / Q000276:immunology / Q000628:therapy* / Q000821:virology; D013601:T-Lymphocytes / Q000276:immunology
D000911:Antibodies, Monoclonal